Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
Shenzhen Hepalink Pharma
Watchlist
Shenzhen Hepalink (海瑞普) A+H: A Heparin-API King but Nothing Too Exciting
Equity Capital Markets
534 Views
19 Feb 2020 08:25
Shenzhen Hepalink is seeking an up to USD 500 million in an A+H listing.The company is a dominant heparin supplier on a global scale but it is not...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 8-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
Equity Bottom-Up
Philippines
Event-Driven
Sell / Short Ideas
Japan
US ECM
India
ASEAN
Unpaywalled Insights
Trending Insights
More »
Solactive Global Uranium & Nuclear Components Index Rebalance: Two Adds & US$1.4bn Trade
[Japan Activism/M&A] Hogy Medical (3593) Reportedly Up For Auction - Totally Unsurprising
GMO Internet (4784) - GMO Internet Parent Has Been SELLING In The Market
Kokusai Electric (6525 JP): Small Index Impact for Now, but Could Lead to Something Bigger
UK: Loans Secured Despite Tax Hike
Top Unpaywalled Insights
More »
Bond Market Monitor: Thailand Unsmiled
Indian Banking’s Longest-Serving, Highest-Paid HR-Head Quits IndusInd Bank
[IO Technicals 2025/30] Iron Ore Rally Cools on Supply Surge, but Policy Hopes Keep Prices Afloat
New Barbarians Podcast | Episode #029 | Recap & Reset: Macro Shifts, Ethereum's Spike, MicroStrat...
Crypto Week Unleashes a Bitcoin Blitz and Sparks the Altcoin Catch-Up
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Shenzhen Hepalink (海瑞普) A+H: A Heparin-API King but Nothing Too Exciting
19 Feb 2020
Okja: The Fight Between Netflix Vs. CJ CGV
05 Jun 2017
Netflix & Amazon Expand in Korea – Not a Coincidence
20 Jan 2016
Thoughts on Amazon –What Does Its Valuation Tells Us?
01 Dec 2015
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.4
x